BCM
OLMA icon

Boxer Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Boxer Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-650,000
Closed -$3.79M – 47
2024
Q4 		$3.79M Buy
+650,000
New +$6.49M 0.32% 45

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Boxer Capital Management's OLMA Position: Q1 2025 in Review

Boxer Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 650,000 shares — an estimated $3.79M sold.

Boxer Capital Management first reported a position in OLMA in Q4 2024 and held it in 1 quarter. The position peaked at $3.79M in Q4 2024. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

  • Boxer Capital Management reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Boxer Capital Management sold 650,000 Olema Pharmaceuticals shares in Q1 2025, an estimated $3.79M.
  • Boxer Capital Management first reported a position in Olema Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Boxer Capital Management's Olema Pharmaceuticals position peaked at $3.79M in Q4 2024.
  • 133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on Boxer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.